Biotechnology
Healthcare
Investing News
Market News
Technology
The Market Buzz
Myovant Sciences Stock Rises After Pfizer Collaboration
Myovant Sciences Ltd. (NYSE: MYOV) stock jumped more than 26% after the clinical-stage biopharmaceutical company announced a collaboration with Pfizer Inc. (NYSE: PFE) to develop and commercialize relugolix – a once-daily, oral gonadotropin-releasing hormone (GnRH)...